Streetbeat News

Price Targets

RHI

BMO Capital analyst Jeffrey Silber has maintained a 'Market Perform' rating on Robert Half (NYSE:RHI) but lowered the price target from $84 to $76.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 2:05 pm

LRCX

JP Morgan analyst Harlan Sur has maintained an Overweight rating on Lam Research (NASDAQ:LRCX) and raised the price target from $550 to $720.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 2:04 pm

GD

JP Morgan analyst Seth Seifman maintains an Overweight rating on General Dynamics (NYSE:GD) and raises the price target from $245 to $251.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 2:04 pm

CSGP

BMO Capital analyst Jeffrey Silber has maintained a 'Market Perform' rating on CoStar Gr (NASDAQ:CSGP) and lowered the price target from $81 to $80.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 2:04 pm

FTV

JP Morgan analyst Stephen Tusa maintains an Overweight rating on Fortive (NYSE:FTV) and raises the price target from $78 to $79.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 2:04 pm

CMG

BMO Capital analyst Andrew Strelzik has maintained a 'Market Perform' rating on Chipotle Mexican Grill (NYSE:CMG) but lowered the price target from $1950 to $1925.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 2:02 pm

FI

JP Morgan analyst Sean Meakim maintains an Overweight rating on Fiserv (NYSE:FI) and raises the price target from $133 to $136.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:59 pm

UNP

BMO Capital analyst Fadi Chamoun has maintained an Outperform rating on Union Pacific (NYSE:UNP) and raised the price target from $240 to $270.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 1:59 pm

RPM

BMO Capital analyst John McNulty has maintained an 'Outperform' rating on RPM International (NYSE:RPM) and raised the price target from $97 to $119.

Portfolio Pulse from richadhand@benzinga.com

July 27, 2023 | 1:58 pm

EW

JP Morgan analyst Robbie Marcus maintains an Overweight rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $95 to $100.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:58 pm